ASCO GUIDELINES Bundle

Laryngeal Cancer Larynx-Preservation

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475469

Contents of this Issue

Navigation

Page 3 of 7

Treatment Limited Stage (T1, T2) ➤ All patients with T1, T2 laryngeal cancer should be treated, at least initially, with intent to preserve the larynx. ➤ T1, T2 laryngeal cancer can be treated with radiation or larynx-preservation surgery with similar survival outcomes. • Selection of treatment depends on patient factors, local expertise, and the availability of appropriate support and rehabilitative services. • Every effort should be made to avoid combining surgery with radiation therapy because functional outcomes may be compromised by combined-modality therapy. • Single-modality treatment is effective for limited-stage, invasive cancer of the larynx. ➤ The success of the larynx preservation approach may be higher with initial larynx-preserving surgery compared to radiation based on retrospective studies. However, this may be subjected to patient selection factors. In experienced hands, endoscopic resections are preferred because of equal or better outcomes compared to open partial laryngectomy unless there are issues with tumor exposure or safety of the endoscopic approach. (Moderate Recommendation; EB-I) ➤ Surgical excision of the primary tumor with intent to preserve the larynx should be undertaken with the aim of achieving tumor-free margins. Surgery that anticipates the need for postoperative radiation therapy to treat close or involved tumor margins or widespread dysplasia is NOT an acceptable treatment approach. (Strong Recommendation; EB-H) ➤ Local tumor recurrence after radiation therapy may be amenable to salvage by organ-preservation surgery, but total laryngectomy will be necessary for a substantial proportion of patients, especially those with index T2 tumors. ➤ Combined chemotherapy and radiation may be used for larynx preservation for selected limited stage patients with: 1. unfavorable or deeply invasive T2 2. T2 N+ cancers 3. patients for whom total laryngectomy may be the only surgical option 4. when the functional outcome after larynx-preservation surgery is expected to be unsatisfactory 5. when surgical expertise for such procedures is not available.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Laryngeal Cancer Larynx-Preservation